Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6.
about
Lipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitusEP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease.Understanding the role of prostaglandin E2 in regulating human platelet activity in health and diseaseRole of COX-2/mPGES-1/prostaglandin E2 cascade in kidney injury.COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes.Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes.Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes MellitusPGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension.Role of the prostaglandin E2 receptor agonists in TGF-β1-induced mesangial cell damagePPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice.New Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy.Chronic kidney disease: targeting prostaglandin E2 receptors.Deficiency of mPGES-1 exacerbates renal fibrosis and inflammation in mice with unilateral ureteral obstruction.Prostaglandins in the pathogenesis of kidney diseases.
P2860
Q28080521-8995D4F1-92E4-4436-B66E-26B42503A9AFQ33794256-83FDA7F0-2E5D-469C-B10C-918BFE4F80E9Q34480894-D686FE49-C010-4849-AA6E-DC10A99BEF6AQ35097808-162A1EB9-A188-4745-92B9-FE2FB68E7F74Q35199315-CBD89471-5172-4CED-800E-CEAFE40D917FQ36063184-82439364-90EF-4B68-9E13-898C4197E41CQ36386660-DCFB198C-987F-4510-8967-564C25024B98Q36624751-DFD163B2-1174-40E5-9021-699A5002D18EQ36797387-7E8045B5-DD23-4759-B0C7-02434E39D1AEQ37294265-5EC510DF-D697-45EA-931E-11E4F569AA61Q37482379-3BD97E4B-DDE4-41F9-9F83-9BDC14C60672Q37590946-E8F6B7A0-6095-4D45-8C35-ED805C351B9CQ38223323-2D0920D5-48DF-434C-893F-1AD65CBFCF3BQ48038002-F2A2A6A7-3274-4DA8-8745-33B3EB1AD145Q55399934-39168E38-5F04-485B-9BCC-5DD4B1624530
P2860
Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Chronic administration of EP4- ...... ed diabetic mice through IL-6.
@en
type
label
Chronic administration of EP4- ...... ed diabetic mice through IL-6.
@en
prefLabel
Chronic administration of EP4- ...... ed diabetic mice through IL-6.
@en
P2093
P2860
P1476
Chronic administration of EP4- ...... ed diabetic mice through IL-6.
@en
P2093
Calpurnia Jayakumar
Ganesan Ramesh
Riyaz Mohamed
P2860
P2888
P304
P356
10.1038/LABINVEST.2013.85
P577
2013-07-01T00:00:00Z